Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olema Oncology
Biotech
Olema, prioritizing oral SERD, plans 25% head count cut
Olema reaffirmed its faith in SERDs by narrowing its focus onto a phase 3 breast cancer program—and put 25% of its people out of work in the process.
Nick Paul Taylor
Mar 10, 2023 8:00am
Fierce JPM Week: Becoming a biotech CEO amid a pandemic
Jan 11, 2021 4:30pm
Olema Oncology brings on AZ vet Bohen as CEO—Chutes & Ladders
Sep 18, 2020 9:30am
Ex-AstraZeneca CMO Bohen lands at Olema Oncology as CEO
Sep 17, 2020 8:00am
